The Ghana Medical Trust Fund (GMTF) has signed a landmark partnership agreement with MDS-Lancet Laboratories Ghana Limited and Quest Medical Imaging to improve access to quality diagnostic services and strengthen healthcare delivery across the country.

The strategic collaboration is expected to enhance early disease detection, improve clinical decision-making and provide Ghanaians with timely, accurate and reliable diagnostic services, particularly for patients living with chronic and non-communicable diseases (NCDs).

The agreement aligns the Ghana Medical Trust Fund’s mandate to support the prevention and treatment of non-communicable diseases with the diagnostic expertise of MDS-Lancet Laboratories Ghana Limited and Quest Medical Imaging, reinforcing a shared commitment to improving health outcomes nationwide.

Speaking at the signing ceremony, the Administrator of the Ghana Medical Trust Fund, Adjoa Obuobia Darko-Opoku, described the agreement as a major milestone in the Fund’s efforts to build strategic partnerships that strengthen healthcare delivery.

She said the collaboration reflects the commitment of the three institutions to making quality healthcare more accessible to Ghanaians.

“Today marks a significant milestone as the Ghana Medical Trust Fund, MDS-Lancet Laboratories Ghana Limited and Quest Medical Imaging formally establish a partnership that reflects our shared commitment to improving access to quality healthcare for the people of Ghana.

Accurate and timely diagnostics are the cornerstone of effective treatment, and this collaboration represents an important investment in the health and wellbeing of Ghanaians.”

Ms Darko-Opoku thanked the leadership of MDS-Lancet Laboratories and Quest Medical Imaging for their confidence in the partnership and reaffirmed GMTF’s commitment to working collaboratively to address Ghana’s growing burden of non-communicable diseases.

Chief Executive Officer of MDS-Lancet Laboratories Ghana Limited, Dr Paul Sekyere-Nyantakyi, welcomed the partnership, saying it aligns with the company’s mission of providing accessible, high-quality diagnostic services that support improved patient care across Ghana.

He expressed optimism that the collaboration would broaden access to advanced diagnostic testing and improve healthcare outcomes for patients.

Officials from the three institutions said the partnership reflects a shared vision to strengthen Ghana’s healthcare system through innovation, expertise and strategic collaboration.

They noted that, beyond expanding access to diagnostic services, the initiative is expected to facilitate early disease detection and support more effective treatment through timely, accurate diagnosis.

The partners reaffirmed their commitment to building a long-term relationship founded on trust, excellence and a common goal of improving lives through quality healthcare.

They also expressed confidence that the collaboration would deliver lasting value to patients and advance equitable and sustainable healthcare across Ghana.